1Slawomir M. Wojtowicz-Praga,Robert B. Dickson,Michael J. Hawkins. Matrix metalloproteinase inhibitors[J] 1997,Investigational New Drugs(1):61～75
2Rocío Garcia Veas,Lothar Schweigerer,Miguel Angel Medina. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity[J] 1995,Journal of Cancer Research and Clinical Oncology(5):275～278
4Advanced Bladder Cancer Meta-analysis Collaboration.Neoadjuvant chemotherapy in invasive bladder cancer:a systematic review and meta-analysis[J].Lancet,2003,361(9373):1927-1934.
5Herr HW,Faulkner JR,Grossman HB,et al.Surgical factors influence bladder cancer outcomes:a cooperative group report[J].J Clin Oncol,2004,22(14):2781-2789.
6Advanced Bladder Cancer(ABC) Meta-analysis Collaboration.Editorial comment on:neoadjuvant chemotherapy in invasive bladder cancer:update of a systematic review and meta-analysis of individual patient data[J].Eur Urol,2005,48(2):205-206.
7David KA,Milowsky MI,Ritchey J,et al.Low incidence of periop-erative chemotherapy for stage Ⅲ bladder cancer 1998 to 2003:a report fromthe National Cancer Data Base[J].J Urol,2007,178 (2):451-454.
8Dash A,Pettus JA 4th,Herr HW,et al.A role for neoadjuvant gem-citabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder; a retrospective experience[J].Cancer,2008,113(9); 2471-2477.
9Abbona A,Morabito F,Rossi R,et al.Quality of life in patients undergone oncopreventive intravesical treatment for superficial bladder cancer[J].Arch Ital Urol Androl,2007,79(4):143-146.
10Cobo M,Delgado R,Gil S,et al.Conservative treatment with tran-surethral resection,neoadjuvant chemotherapy followed by radio-chemotherapy in stage T2-3 transitional bladder cancer[J].Clin Transl Oncol,2006,8(12):903-911.
